Deutsche Bank upgrades AstraZeneca stock rating to hold on trial results
Reported by Investing.com · investing.com ·
Story context
What to watch: AZN (AZN) was upgraded by an analyst — weigh the new price target against where shares already trade before treating it as new information.
Latest session change: $AZN -0.45%
- $AZN earningsThu, Nov 5 · in 51 daysAstraZeneca PLC
Confirmed dates for the names in this story. Listed because they are scheduled, not because this story affects them.
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
